A special app is used to evaluate the impact of the disease on the everyday life of patients and their families.

DZNE researchers report in the journal "Cell".

The vaccine is targeting the most common genetic ALS variant.

Rhineland Study: The Extent of Abnormalities in the Brain’s White Matter Grows Significantly After Menopause.

Researchers from DZNE have identified a protein in the blood that may indicate the degradation of neural connections years before the onset of dementia symptoms.

Novel Data Analysis Method Helps Uncover Hidden Disease Mechanisms.

New evidence on subjective impairments in cognitive performance

Neuroscientist Michel Goedert from Cambridge, UK, has received the "Hartwig Piepenbrock DZNE Prize", which is endowed with 60,000 euros.

DZNE study provides new insights into pathological phenomena of Alzheimer‘s disease.

A European research consortium led by DZNE will be investigating the neurodegenerative disease “Spinocerebellar Ataxia Type 3” (SCA3) in collaboration with the French pharmaceutical company Servier Laboratories.